Trademark: 90662890
Word
D3 BIO
Status Date
Thursday, March 7, 2024
Filing Date
Thursday, April 22, 2021
Published for Opposition
Tuesday, July 25, 2023
42 Drug evaluation, namely, pharmaceutical product evaluation; pharmaceutical research; pharmaceutical drug development services; research services in the field of pharmaceutical drugs; scientific research for medical purposes in the field of cancer; biological research; scientific research in the nature of conducting clinical trials for others; medical research; research and development of antibodies; development of pharmaceutical preparations and pharmaceuticals; none of the foregoing in the field of radiation oncology
The mark consists of the words "D3 BIO" in black all caps below three Chinese characters in red, all to the right of a rounded red zig-zag design centered on a red vertical line.
D THREE BIO
The color(s) red and black is/are claimed as a feature of the mark.
The non-Latin characters in the mark transliterate to "DeShengJi" and this means "Moral Rise Aid" in English.
"BIO"
Mar 8, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2024
Sou Extension 1 Granted
Mar 7, 2024
Sou Extension 1 Filed
Mar 7, 2024
Sou Teas Extension Received
Sep 19, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 25, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2023
Published For Opposition
Jul 5, 2023
Notification Of Notice Of Publication E-Mailed
Jun 16, 2023
Approved For Pub - Principal Register
Jul 25, 2022
Teas/Email Correspondence Entered
Jul 25, 2022
Correspondence Received In Law Office
Jul 23, 2022
Assigned To Lie
Jul 5, 2022
Teas Response To Office Action Received
Jan 5, 2022
Notification Of Non-Final Action E-Mailed
Jan 5, 2022
Non-Final Action E-Mailed
Jan 5, 2022
Non-Final Action Written
Dec 17, 2021
Assigned To Examiner
Jul 29, 2021
Notice Of Design Search Code E-Mailed
Jul 28, 2021
New Application Office Supplied Data Entered
Apr 26, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
